|
SNX27 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.383100E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.280100E-02 |
| Normal-vs-Stage2 |
3.246600E-01 |
| Normal-vs-Stage3 |
1.086400E-02 |
| Normal-vs-Stage4 |
1.221790E-03 |
| Stage1-vs-Stage2 |
4.196800E-01 |
| Stage1-vs-Stage3 |
3.718600E-01 |
| Stage1-vs-Stage4 |
2.307800E-02 |
| Stage2-vs-Stage3 |
1.587180E-01 |
| Stage2-vs-Stage4 |
1.070010E-02 |
| Stage3-vs-Stage4 |
8.908100E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.756500E-03 |
| Normal-vs-AfricanAmerican |
1.411540E-02 |
| Normal-vs-Asian |
6.748400E-02 |
| Caucasian-vs-AfricanAmerican |
2.207400E-01 |
| Caucasian-vs-Asian |
8.641000E-01 |
| AfricanAmerican-vs-Asian |
2.241600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.281900E-03 |
| Normal-vs-Female |
7.257300E-03 |
| Male-vs-Female |
4.632200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.077640E-02 |
| Normal-vs-Age(41-60Yrs) |
2.942400E-02 |
| Normal-vs-Age(61-80Yrs) |
7.643100E-03 |
| Normal-vs-Age(81-100Yrs) |
5.827600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.777400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.996400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.784400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.184600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.957000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.856600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.286600E-01 |
| Classical-VS-Follicular |
1.1210999995015E-07 |
| Classical-VS-Other |
1.722210E-01 |
| Classical-VS-Normal |
1.555590E-04 |
| Tall-VS-Follicular |
4.29120000000616E-06 |
| Tall-VS-Other |
3.443800E-02 |
| Tall-VS-Normal |
1.839130E-04 |
| Follicular-VS-Other |
9.071000E-01 |
| Follicular-VS-Normal |
5.347400E-01 |
| Other-VS-Normal |
8.605000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.138600E-01 |
| Normal-vs-N1 |
8.877700E-02 |
| N0-vs-N1 |
3.151800E-01 |
|
|
